Matinas BioPharma Holdings (MTNB) Long-Term Investments (2013 - 2025)
Matinas BioPharma Holdings (MTNB) reported Long-Term Investments of $70000.0 for Q3 2025, little changed quarter-over-quarter from $70000.0 in Q2 2025.
Matinas BioPharma Holdings (MTNB) Long-Term Investments (2013 - 2025) Analysis & Trends
Matinas BioPharma Holdings (MTNB) has 6 years of Long-Term Investments data on file, last reported at $70000.0 in Q3 2025.
- Long-Term Investments for Q3 2025 came in at $70000.0, changed N/A year-over-year; the trailing twelve-month figure through Sep 2025 was $70000.0 (changed N/A YoY), and the FY2017 annual result was $535999.0, down 0.9% from the prior year.
- Long-Term Investments was little changed at $70000.0 in Q3 2025 per MTNB's latest filing, from $70000.0 in the prior quarter.
- Over five years, Long-Term Investments peaked at $70000.0 in Q2 2025 and troughed at $70000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 5.17 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 5.75 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Matinas BioPharma Holdings | 4.60 Mn | 2.15 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 70,000.00 |
| Jun 30, 2025 | 70,000.00 |
| Dec 31, 2017 | 535,999.00 |
| Sep 30, 2017 | 535,999.00 |
| Jun 30, 2017 | 536,001.00 |
| Mar 31, 2017 | 540,145.00 |
| Dec 31, 2016 | 540,845.00 |
| Sep 30, 2016 | 54,844.00 |
| Jun 30, 2016 | 54,844.00 |
| Mar 31, 2016 | 115,371.00 |
| Dec 31, 2015 | 115,370.00 |
| Sep 30, 2015 | 216,555.00 |
| Jun 30, 2015 | 216,475.00 |
| Mar 31, 2015 | 216,395.00 |
| Dec 31, 2014 | 216,317.00 |
| Sep 30, 2014 | 316,225.00 |
| Jun 30, 2014 | 316,105.00 |
| Mar 31, 2014 | 315,986.00 |
| Dec 31, 2013 | 315,778.00 |